X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6662) 6662
Publication (675) 675
Book Review (82) 82
Book Chapter (71) 71
Dissertation (19) 19
Conference Proceeding (14) 14
Data Set (1) 1
Government Document (1) 1
Magazine Article (1) 1
Paper (1) 1
Reference (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
plasminogen-activator inhibitor-1 (3960) 3960
humans (3794) 3794
index medicus (2252) 2252
animals (2065) 2065
male (1758) 1758
female (1646) 1646
plasminogen activator inhibitor-1 (1522) 1522
hematology (1048) 1048
peripheral vascular disease (1036) 1036
middle aged (1031) 1031
biochemistry & molecular biology (984) 984
mice (915) 915
adult (896) 896
fibrinolysis (816) 816
expression (760) 760
plasminogen activator inhibitor 1 - genetics (739) 739
risk factors (713) 713
cell biology (657) 657
aged (654) 654
plasminogen activator inhibitor 1 - metabolism (624) 624
myocardial-infarction (621) 621
pai-1 (589) 589
plasminogen activator inhibitor 1 - blood (565) 565
endocrinology & metabolism (512) 512
inflammation (512) 512
endothelial-cells (504) 504
insulin-resistance (497) 497
rats (477) 477
cells, cultured (467) 467
gene-expression (466) 466
obesity (458) 458
thrombosis (437) 437
cardiac & cardiovascular systems (415) 415
research (410) 410
atherosclerosis (398) 398
insulin resistance (395) 395
proteins (383) 383
oncology (381) 381
c-reactive protein (361) 361
gene expression (359) 359
analysis (358) 358
pharmacology & pharmacy (352) 352
article (348) 348
medicine, research & experimental (342) 342
physiological aspects (342) 342
apoptosis (337) 337
disease (327) 327
necrosis-factor-alpha (311) 311
risk (308) 308
metabolic syndrome (307) 307
in-vivo (301) 301
growth-factor-beta (295) 295
inhibitor-1 (293) 293
health aspects (292) 292
plasma (291) 291
signal transduction (291) 291
cardiovascular-disease (290) 290
oxidative stress (289) 289
coagulation (285) 285
mice, inbred c57bl (285) 285
genetic aspects (280) 280
cancer (278) 278
polymorphism, genetic (277) 277
cells (267) 267
physiology (265) 265
hypertension (260) 260
case-control studies (259) 259
genotype (258) 258
tissue plasminogen activator (257) 257
fibrosis (256) 256
diabetes (254) 254
time factors (250) 250
bax inhibitor-1 (249) 249
rna, messenger - metabolism (248) 248
angiogenesis (242) 242
urology & nephrology (240) 240
disease models, animal (236) 236
biomarkers - blood (231) 231
smooth-muscle-cells (230) 230
messenger-rna (222) 222
adipose-tissue (218) 218
adolescent (217) 217
type-1 (217) 217
risk-factors (215) 215
gene (206) 206
immunology (206) 206
medicine, general & internal (206) 206
prognosis (206) 206
in-vitro (205) 205
mice, knockout (204) 204
tgf-beta (203) 203
hemostasis (202) 202
coronary-heart-disease (201) 201
polymorphism (200) 200
system (197) 197
body mass index (195) 195
extracellular-matrix (194) 194
fibrinogen (192) 192
receptor (192) 192
coronary-artery-disease (191) 191
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6554) 6554
Japanese (42) 42
French (23) 23
Korean (20) 20
German (19) 19
Russian (19) 19
Spanish (17) 17
Chinese (10) 10
Polish (9) 9
Portuguese (2) 2
Turkish (2) 2
Bosnian (1) 1
Croatian (1) 1
Greek (1) 1
Indonesian (1) 1
Persian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Thrombosis Research, ISSN 0049-3848, 08/2019, Volume 180, pp. 110 - 114
Different studies have recognized the existence of subtypes of obesity and normal weight, in which it is reported that not all patients show the same... 
Obesity | Plasminogen activator inhibitor-1 | Thrombosis | Fibrinolysis
Journal Article
CELLULAR SIGNALLING, ISSN 0898-6568, 03/2018, Volume 43, pp. 1 - 10
Fibrotic disorders of the renal, pulmonary, cardiac, and hepatic systems are associated with significant morbidity and mortality. Effective therapies to... 
TGF-BETA | TGF-beta 1 | Plasminogen activator Inhibitor-1 | INJURY | PLASMINOGEN-ACTIVATOR INHIBITOR-1 | Kidney | p53 | CELL BIOLOGY | Fibrosis | TUBULOINTERSTITIAL FIBROSIS | GENE-EXPRESSION | INTERSTITIAL FIBROSIS | PAI-1 | CHRONIC KIDNEY-DISEASE | URETERAL OBSTRUCTION
Journal Article
CRITICAL CARE MEDICINE, ISSN 0090-3493, 08/2007, Volume 35, Issue 8, pp. 1821 - 1828
Objective: The coagulation and inflammatory cascades may be linked in the pathogenesis of acute lung injury and acute respiratory distress syndrome. However,... 
MORTALITY | RISK-FACTORS | ACTIVATED PROTEIN-C | MYOCARDIAL-INFARCTION | ABNORMALITIES | ALVEOLAR FLUID CLEARANCE | coagulation | fibrinolysis | INHIBITOR-1 | plasminogen activator inhibitor-1 | VENTILATION | ANGINA-PECTORIS | acute respiratory distress syndrome | protein C | SEVERE SEPSIS | CRITICAL CARE MEDICINE
Journal Article
Circulation Research, ISSN 0009-7330, 05/2012, Volume 110, Issue 11, pp. 1484 - 1497
RATIONALE:Pulmonary arterial hypertension (PAH) is a lethal syndrome characterized by pulmonary vascular obstruction caused, in part, by pulmonary artery... 
mitotic checkpoint | cyclin B1/cyclin-dependent kinase 1 | mitochondrial fission | hypoxia-inducible factor-1 | mitochondrial division inhibitor-1 | CARDIAC & CARDIOVASCULAR SYSTEMS | ENTRY | INDUCIBLE FACTOR 1-ALPHA | HYPOXIA | DRP1 | PATHWAY | ARTERIAL-HYPERTENSION | ENDOTHELIAL-CELLS | GENE-EXPRESSION | GERMLINE MUTATIONS | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | K+ CHANNELS | Antihypertensive Agents - pharmacology | Humans | Monocrotaline | Male | Cyclin B1 - metabolism | Cobalt | Hypertension, Pulmonary - therapy | CDC2 Protein Kinase - metabolism | RNA Interference | Time Factors | Hypoxia-Inducible Factor 1, alpha Subunit - metabolism | Mitochondrial Proteins - metabolism | Myocytes, Smooth Muscle - drug effects | Hypertension, Pulmonary - enzymology | Disease Models, Animal | Muscle, Smooth, Vascular - drug effects | Myocytes, Smooth Muscle - enzymology | Dynamins - genetics | Rats | Familial Primary Pulmonary Hypertension | Hypoxia - complications | Rats, Sprague-Dawley | Pulmonary Artery - enzymology | Cell Cycle Checkpoints | GTP Phosphohydrolases - metabolism | GTP Phosphohydrolases - genetics | Mitochondria, Muscle - drug effects | Enzyme Activation | Hypertension, Pulmonary - etiology | Muscle, Smooth, Vascular - enzymology | Dynamins - metabolism | Phosphorylation | Microtubule-Associated Proteins - genetics | Microtubule-Associated Proteins - metabolism | Serine | Myocytes, Smooth Muscle - pathology | Mitochondrial Proteins - genetics | Case-Control Studies | Transfection | Quinazolinones - pharmacology | Mitochondria, Muscle - enzymology | Mitochondria, Muscle - pathology | Cells, Cultured | Muscle, Smooth, Vascular - pathology | Animals | Mitosis - drug effects | Glycolysis | Cell Proliferation - drug effects | Hypertension, Pulmonary - pathology | Pulmonary Artery - pathology | Genetic Therapy - methods | Hypoxia-inducible factor 1 | CDK1-cyclin B1 | Mitochondrial division inhibitor-1 (Mdivi-1) | Mitochondrial fission | Mitotic check point
Journal Article
Journal Article
European Neuropsychopharmacology, ISSN 0924-977X, 2014, Volume 24, Issue 12, pp. 1982 - 1999
Abstract Obesity is a pandemic and a serious global health concern. Obesity is a risk factor for multiple conditions and contributes to multi-morbidities,... 
Internal Medicine | Psychiatry | Obesity | Brain | Adipokines | Alzheimer | Leptin | Dementia | VASCULAR RISK-FACTORS | PSYCHIATRY | HUMAN CEREBROSPINAL-FLUID | PLASMINOGEN-ACTIVATOR INHIBITOR-1 | Adipokinesi | MILD COGNITIVE IMPAIRMENT | NEUROSCIENCES | CLINICAL NEUROLOGY | TUMOR-NECROSIS-FACTOR | RENIN-ANGIOTENSIN SYSTEM | BODY-MASS INDEX | PHARMACOLOGY & PHARMACY | CENTRAL-NERVOUS-SYSTEM | LONG-TERM POTENTIATION | NF-KAPPA-B | Tumor Necrosis Factor-alpha - metabolism | Obesity - complications | Brain - physiopathology | Humans | Leptin - metabolism | Angiotensinogen - metabolism | Dementia - physiopathology | Obesity - physiopathology | Adipokines - metabolism | Brain - metabolism | Animals | Dementia - complications | Plasminogen Activator Inhibitor 1 - metabolism | Models, Biological | Adiponectin - metabolism | Interleukin-6 - metabolism | Neurosciences | Alzheimer's disease | Angiotensin | dementia | adipokines | brain | leptin | ORNETTA RL | P2999 | PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF | P1444 | ENG B | NETICS | Clinical Neurology | PLASMINOGEN-ACTIVATOR | 1994 | NCREDI V | NEUROSCIENCE LETTERS | 1992 | LSTED A | Pharmacology & Pharmacy | SCIENCE | JOURNAL OF IMMUNOLOGY | Neurovetenskaper | LONG-TERM | P139 | P176 | 1990 | P1056 | INHIBITOR-1 | CENTRAL LEPTIN RESISTANCE | POTENTIATION | UNG IY | V12 | V147B | V146 | V144 | V242 | NEURON | 1988
Journal Article
THROMBOSIS RESEARCH, ISSN 0049-3848, 08/2019, Volume 180, pp. 110 - 114
Background: Different studies have recognized the existence of subtypes of obesity and normal weight, in which it is reported that not all patients show the... 
Obesity | PLASMINOGEN-ACTIVATOR INHIBITOR-1 | RISK | Plasminogen activator inhibitor-1 | Thrombosis | Fibrinolysis | INDIVIDUALS | DENSITY | PLASMA | INSULIN-RESISTANCE | INFLAMMATION | CARDIOVASCULAR-DISEASE | PERIPHERAL VASCULAR DISEASE | HYPERTENSION | HEMATOLOGY | ADIPOSE-TISSUE | Phenotype | Analysis | Physiological aspects | Genetic aspects | Blood clot
Journal Article
Biological Rhythm Research, ISSN 0929-1016, 2019, pp. 1 - 11
Journal Article
Cellular Signalling, ISSN 0898-6568, 03/2018, Volume 43, pp. 1 - 10
Fibrotic disorders of the renal, pulmonary, cardiac, and hepatic systems are associated with significant morbidity and mortality. Effective therapies to... 
TGF-β1 | Plasminogen activator Inhibitor-1 | Kidney | Fibrosis | p53 | Plasminogen Activator Inhibitor-1
Journal Article
Molecular Therapy, ISSN 1525-0016, 02/2019, Volume 27, Issue 2, pp. 342 - 354
Journal Article